Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.

Experimental Therapeutics, Mood and Anxiety Disorders Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA.
Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology (Impact Factor: 7.83). 06/2010; 35(7):1415-22. DOI: 10.1038/npp.2010.24
Source: PubMed

ABSTRACT Pregenual anterior cingulate cortex (pgACC) hyperactivity differentiates treatment responders from non-responders to various pharmacological antidepressant interventions, including ketamine, an N-methyl-D-aspartate receptor antagonist. Evidence of pgACC hyperactivition during non-emotional working memory tasks in patients with major depressive disorder (MDD) highlights the importance of this region for processing both emotionally salient and cognitive stimuli. However, it is unclear whether pgACC activity might serve as a potential biomarker of antidepressant response during working memory tasks as well, in line with previous research with emotionally arousing tasks. This study tested the hypothesis that during the N-back task, a widely used working memory paradigm, low pretreatment pgACC activity, as well as coherence between the pgACC and the amygdala, would be correlated with the clinical improvement after ketamine. Magnetoencephalography (MEG) recordings were obtained from 15 drug-free patients with MDD during working memory performance 1 to 3 days before receiving a single ketamine infusion. Functional activation patterns were analyzed using advanced MEG source analysis. Source coherence analyses were conducted to quantify the degree of long-range functional connectivity between the pgACC and the amygdala. Patients who showed the least engagement of the pgACC in response to increased working memory load showed the greatest symptomatic improvement within 4 h of ketamine administration (r=0.82, p=0.0002, false discovery rate (FDR) <0.05). Pretreatment functional connectivity between the pgACC and the left amygdala was negatively correlated with antidepressant symptom change (r=-0.73, p=0.0021, FDR <0.05).These data implicate the pgACC and its putative interaction with the amygdala in predicting antidepressant response to ketamine in a working memory task context.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The prevalence of depression has been shown to be increased with the presence of chronic inflammatory and/or autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, type II diabetes mellitus and cardiovascular diseases. It has been well documented in the last decade that inflammation in the periphery could interact within the central nervous system. Once an inflammatory stimulus reaches the brain, microglial cells serve as fundamental sensory complements by playing an important role in neuroinflammation which is a necessary process required for brain development. However, the process itself, if excessive or prolonged, can turn into a pathological condition and become a causative factor of the disease, for example, in the case of chronic stress or depression. The association between high plasma levels of pro-inflammatory cytokines and depression has been shown by several clinical and experimental studies. In addition, current antidepressant therapies reduce high cytokine levels of depressive patients and antidepressant-like effects are observed with the use of immunosuppressant drugs acting on cytokine-mediated mechanisms. On the other hand, inflammatory cytokines are known to mediate the activity of the hypothalamic-pituitary axis (HPA) which is well known to be elevated in depression and stress, resulting in a further contribution to the inflammatory state. At present, approximately of patients with depression do not respond to current antidepressant therapies. Thus, great efforts have been made in many studies to provide novel therapeutic approaches for depression. At this point, targeting initiator molecular mechanisms of cytokine-mediated inflammatory responses has become an intriguing approach for preventing the process before the production and release of these inflammatory mediators. Herein, we have aimed to draw attention to a novel aspect of the cytokine hypothesis of depression that may serve as a novel target mechanism and provide further understanding of the disease, namely NLRP3 inflammasome, a multi protein complex formed in macrophage and microglia cells which is responsible for initiating the inflammatory responses mediated with IL-1 beta and IL-18.
    Bulletin of Clinical Psychopharmacology 09/2013; 23(3):1. DOI:10.5455/bcp.20130927070724 · 0.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: With a life time prevalence estimated at 16%, major depression (MD) is a major public health issue. Previous studies have shown that depression has been associated with a variety of cognitive impairments. In addition to cognitive impairments, major depression is usually accompanied by alterations of cortical activity, especially in prefrontal areas. Recent studies have highlighted the importance of noninvasive brain stimulation as a means of modulating cortical excitability. Recent studies on major depression (MD) have revealed that transcranial direct current stimulation induces cortical excitability which facilitates memory and especially working memory. On the other hand visual aspects of memory in MD have not been yet investigated. Objective: This study aimed to investigate whether anodal and cathodal tDCS applied over dorsolateral prefrontal cortex (DLPFC), would significantly improve visual memory in patients with major depression. Methods: Thirty (N=30) patients with major depression were randomly assigned to receive either experimental(active) or control (sham) tDCS. The participants underwent a series of visual memory tasks before and after 10 sessions of tDCS. The parameters of active tDCS included 2 mA for 20 minutes per day for 10 consecutive days, anode over the left DLPFC (F3), cathode over the right DLPFC (F4) region. Results: After 10 sessions of anodal and cathodal tDCS, patients showed significantly improved performance in visual and spatial aspects of memory tasks. Specifically, anodal stimulation improved visual memory perfo rmance for the experimental group relative to baseline, whereas sham stimulation did not differentiate performance from baseline in the control group. Conclusion: This study showed that anodal tDCS over DLPFC concurrently with cathodal tDCS over right DLPFC improved visual and spatial aspects of memory in patients with MD. This finding is in generally consistent with previous findings about effectiveness of tDCS on cognition in major depression, while additionally provides support for effectiveness of tDCS on visual memory in MD. Keywords: Major depression, memory, tDCS, visual memory
  • Source
    Neurology Psychiatry and Brain Research 03/2012; 18(2):92. DOI:10.1016/j.npbr.2012.02.043 · 0.10 Impact Factor

Full-text (2 Sources)

Available from
May 22, 2014